Similar articles for PMID: 9709461

Year	Number of Results
1946	1
1990	6
1991	3
1992	4
1993	3
1994	11
1995	9
1996	7
1997	14
1998	9
1999	8
2000	5
2001	1
2005	1
2007	1
2008	1
2017	1
2020	1
2024	0

1

Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.

Walker AS, Peto TE, Babiker AG, Darbyshire JH. Walker AS, et al. QJM. 1998 Jun;91(6):423-38. doi: 10.1093/qjmed/91.6.423. QJM. 1998. PMID: 9709461

2

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.

[No authors listed] [No authors listed] Lancet. 1994 Apr 9;343(8902):871-81. Lancet. 1994. PMID: 7908356 Clinical Trial.

3

Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.

Goldstein G, Conant MA, Beall G, Grossman HA, Galpin JE, Blick G, Calabrese LH, Hirsch RL, Fisher A, Stampone P, et al. Goldstein G, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):279-88. doi: 10.1097/00042560-199503010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7859140 Clinical Trial.

4

Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.

[No authors listed] [No authors listed] AIDS. 1994 Jul;8(7):911-21. AIDS. 1994. PMID: 7946100

5

Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.

Molina JM, Ferchal F, Chevret S, Barateau V, Poirot C, Morinet F, Modai J. Molina JM, et al. AIDS. 1994 Jan;8(1):27-33. doi: 10.1097/00002030-199401000-00005. AIDS. 1994. PMID: 7912084

6

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, Rubin M, Simberkoff MS, Hamilton JD. O'Brien WA, et al. N Engl J Med. 1996 Feb 15;334(7):426-31. doi: 10.1056/NEJM199602153340703. N Engl J Med. 1996. PMID: 8552144 Free article.

7

Monitoring antiretroviral activity using ICDp24 and CD4 counts in HIV infection.

Lillo FB, Maillard M, Saracco A, Varnier OE. Lillo FB, et al. J Infect. 1997 Jul;35(1):67-71. doi: 10.1016/s0163-4453(97)91049-5. J Infect. 1997. PMID: 9279727

8

Zidovudine and lamivudine: results of phase III studies.

Staszewski S. Staszewski S. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S57. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8595510 Clinical Trial.

9

Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.

Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J, et al. Jacobson MA, et al. BMJ. 1991 Jan 12;302(6768):73-8. doi: 10.1136/bmj.302.6768.73. BMJ. 1991. PMID: 1671651 Free PMC article.

10

Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.

Siller L, Martin NL, Kostuchenko P, Beckett L, Rautonen J, Cheng SC, Wara DW. Siller L, et al. AIDS. 1993 Mar;7(3):369-73. doi: 10.1097/00002030-199303000-00010. AIDS. 1993. PMID: 8097095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year